Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Lexaria Bioscience | LEXX | Nov 7, 2024 | 2.32 | +5.94 |
Lexeo Therapeutics | LXEO | Nov 7, 2024 | 7.89 | -3.78 |
Lexicon Pharmaceuticals | LXRX | Nov 7, 2024 | 1.30 | +7.44 |
LexinFintech ADR | LX | Nov 7, 2024 | 3.91 | +8.91 |
LG Display ADR | LPL | Nov 7, 2024 | 3.60 | 0.00 |
LGI Homes | LGIH | Nov 7, 2024 | 109.67 | -0.28 |
LGL Group | LGL | Nov 7, 2024 | 5.85 | -2.01 |
Li Auto ADR | LI | Nov 7, 2024 | 25.61 | +3.64 |
Li Bang International | LBGJ | Nov 7, 2024 | 4.05 | 0.00 |
Li-Cycle | LICY | Nov 7, 2024 | 3.61 | +13.52 |
Liberty Allstar Equity Fund | USA | Nov 7, 2024 | 7.40 | +1.65 |
Liberty Allstar Growth Fund | ASG | Nov 7, 2024 | 5.95 | +2.06 |
Liberty Broadband A | LBRDA | Nov 7, 2024 | 95.89 | -4.35 |
Liberty Broadband A Pref | LBRDP | Nov 7, 2024 | 23.85 | -0.21 |
Liberty Broadband C | LBRDK | Nov 7, 2024 | 96.98 | -4.36 |
Liberty Global A | LBTYA | Nov 7, 2024 | 19.83 | -0.45 |
Liberty Global B | LBTYB | Nov 7, 2024 | 19.99 | 0.00 |
Liberty Global C | LBTYK | Nov 7, 2024 | 20.42 | -0.49 |
Liberty Latin America | LILA | Nov 7, 2024 | 8.24 | -20.77 |
Liberty Latin America | LILAK | Nov 7, 2024 | 8.13 | -20.61 |
Liberty Media A | LLYVA | Nov 7, 2024 | 60.64 | -1.27 |
Liberty Media A Formula One | FWONA | Nov 7, 2024 | 73.99 | -3.58 |
Liberty Media C | LLYVK | Nov 7, 2024 | 62.44 | -0.89 |
Liberty Media C Formula One | FWONK | Nov 7, 2024 | 80.54 | -2.80 |
Liberty Oilfield Services A | LBRT | Nov 7, 2024 | 17.93 | -5.63 |
Lichen China | LICN | Nov 7, 2024 | 1.96 | -2.97 |
Life Time Group | LTH | Nov 7, 2024 | 24.65 | +3.14 |
Life360 | LIF | Nov 7, 2024 | 47.04 | +2.73 |
Lifecore Biomedical | LFCR | Nov 7, 2024 | 6.39 | -0.31 |
LifeMD | LFMD | Nov 7, 2024 | 5.13 | +1.38 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.